(Q38328139)

English

Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

scientific article

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

title

Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Bin-Chi Liao

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

author name string

Chia-Chi Lin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

language of work or name

1 reference

1 March 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

retrieved

2 September 2017

published in

Current Opinion in Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

page(s)

94-101

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

cites work

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

DOI

10.1097/CCO.0000000000000164

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

PubMed publication ID

25611025

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25611025

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25611025%20AND%20SRC:MED&resulttype=core&format=json

(Q38328139)

Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)